Development of an mRNA replacement therapy for phenylketonuria
Phenylketonuria (PKU) is an inborn error caused by deficiencies in phenylalanine (Phe) metabolism. Mutations in the phenylalanine hydroxylase (PAH) gene are the main cause of the disease whose signature hallmarks of toxically elevated levels of Phe accumulation in plasma and organs such as the brain...
Saved in:
Main Authors: | Carlos G. Perez-Garcia (Author), Ramon Diaz-Trelles (Author), Jerel Boyd Vega (Author), Yanjie Bao (Author), Marciano Sablad (Author), Patty Limphong (Author), Simon Chikamatsu (Author), Hailong Yu (Author), Wendy Taylor (Author), Priya P. Karmali (Author), Kiyoshi Tachikawa (Author), Padmanabh Chivukula (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Restoring ornithine transcarbamylase (OTC) activity in an OTC‐deficient mouse model using LUNAR‐OTC mRNA
by: Hailong Yu, et al.
Published: (2022) -
Selective suppression of polyglutamine-expanded protein by lipid nanoparticle-delivered siRNA targeting CAG expansions in the mouse CNS
by: Tomoki Hirunagi, et al.
Published: (2021) -
A lipid nanoparticle-based oligodendrocyte-specific mRNA therapy
by: Masanori Sawamura, et al.
Published: (2024) -
Maternal phenylketonuria
by: Kristina Štuikienė, et al.
Published: (2013) -
mRNA in the Context of Protein Replacement Therapy
by: Theofanis Vavilis, et al.
Published: (2023)